Save your place

Sign in to WhoBought

Please try again later.

Oramed Pharmaceuticals Inc. (ORMP) institutional ownership

Latest close $4.02 Jul 21, 2026
Market cap$87M 52-week range SectorHealthcare
Funds holding · Q1 2026
59
reported ORMP position changes
Top owners · Q1 2026
No disclosed owners are available.
Institutional activity · Q1 2026
Activity unavailable N/A
35 buyers · 24 sellers

Oramed Pharmaceuticals Inc. (ORMP) price and institutional activity

Dates

Q1 2026

$0 bought by 35 investors
Mercer Global Advisors IncRitholtz Wealth Management +33 more
$0 sold by 24 investors
Gem Investment Advisors, LLCCitadel Advisors LLC +22 more
Bought Sold Totals per quarter; hover a bar for the names.

Oramed Pharmaceuticals Inc. (ORMP) institutional activity · 59

Investor Type Est. change Change Δ Own Date
Mercer Global Advisors Inc · New
Change +1.9M Date Q1 2026
Mercer Global Advisors Inc New· Q1 2026 +1.9M Q1 2026
Gem Investment Advisors, LLC · Reduced
Change −359K Date Q1 2026
Gem Investment Advisors, LLC Reduced· Q1 2026 −359K Q1 2026
Ritholtz Wealth Management · New
Change +155K Date Q1 2026
Ritholtz Wealth Management New· Q1 2026 +155K Q1 2026
Aquamarine Financial (cayman) Ltd · Added
Change +139K Date Q1 2026
Aquamarine Financial (cayman) Ltd Added· Q1 2026 +139K Q1 2026
O'Shaughnessy Asset Management, LLC · New
Change +116K Date Q1 2026
O'Shaughnessy Asset Management, LLC New· Q1 2026 +116K Q1 2026
Susquehanna International Group, LLP · Added
Change +110K Date Q1 2026
Susquehanna International Group, LLP Added· Q1 2026 +110K Q1 2026
Citadel Advisors LLC Reduced· Q1 2026 −97K −49.7% Q1 2026
Hillsdale Investment Management Inc. · New
Change +97K Date Q1 2026
Hillsdale Investment Management Inc. New· Q1 2026 +97K Q1 2026
Squarepoint Ops LLC · Exited
Change −58K Δ Own −100.0% Date Q1 2026
Squarepoint Ops LLC Exited· Q1 2026 −58K −100.0% Q1 2026
Hudson Bay Capital Management LP · New
Change +52K Date Q1 2026
Hudson Bay Capital Management LP New· Q1 2026 +52K Q1 2026
Rbf Capital, LLC · Exited
Change −43K Δ Own −100.0% Date Q1 2026
Rbf Capital, LLC Exited· Q1 2026 −43K −100.0% Q1 2026
Quadrature Capital Ltd · Exited
Change −42K Δ Own −100.0% Date Q1 2026
Quadrature Capital Ltd Exited· Q1 2026 −42K −100.0% Q1 2026
Bailard, Inc. · New
Change +32K Date Q1 2026
Bailard, Inc. New· Q1 2026 +32K Q1 2026
Wells Fargo & Company · Added
Change +27K Date Q1 2026
Wells Fargo & Company Added· Q1 2026 +27K Q1 2026
Jane Street Group, LLC · Reduced
Change −26K Date Q1 2026
Jane Street Group, LLC Reduced· Q1 2026 −26K Q1 2026
Data through Q1 2026 · filed Jun 9, 2026
15 of 59

Famous investor activity in Oramed Pharmaceuticals Inc. (ORMP)

Oramed Pharmaceuticals Inc. (ORMP) insider trading

Company insiders, action and economics first; trade and filed dates last.
Dates
Insider Title Type Price Qty Value Owned ΔOwn Trade date Filed date
Hexter Joshua · Officer 2 operations 0
Price $3.69 Owned 50K Trade date Jul 2, 2026 Filed date Jul 2, 2026
Hexter Joshua Officer 2 operations $3.69 0 50K Jul 2, 2026 Jul 2, 2026
Hexter Joshua · Officer Sell −$611K
Price $4.46 Qty −137K Owned 1.0M ΔOwn −11.8% Trade date Jul 1, 2026 Filed date Jul 2, 2026
Hexter Joshua Officer Sell $4.46 −137K −$611K 1.0M −11.8% Jul 1, 2026 Jul 2, 2026
Gabay Avraham · Officer Sell −$331K
Price $4.51 Qty −73K Owned 672K ΔOwn −9.8% Trade date Jul 1, 2026 Filed date Jul 2, 2026
Gabay Avraham Officer Sell $4.51 −73K −$331K 672K −9.8% Jul 1, 2026 Jul 2, 2026
Kidron Nadav · Director, Officer Tax withholding or exercise payment (F) -$148K
Price $3.31 Qty -45K Owned 3.4M Trade date Mar 30, 2026 Filed date Mar 31, 2026
Kidron Nadav Director, Officer Tax withholding or exercise payment (F) $3.31 -45K -$148K 3.4M Mar 30, 2026 Mar 31, 2026
Kidron Miriam · Director, Officer Tax withholding or exercise payment (F) -$1.4M
Price $3.31 Qty -435K Owned 1.1M Trade date Mar 30, 2026 Filed date Mar 31, 2026
Kidron Miriam Director, Officer Tax withholding or exercise payment (F) $3.31 -435K -$1.4M 1.1M Mar 30, 2026 Mar 31, 2026
Kidron Miriam · Director, Officer Grant (A) 120K
Owned 1.6M Trade date Mar 17, 2026 Filed date Mar 18, 2026
Kidron Miriam Director, Officer Grant (A) 120K 1.6M Mar 17, 2026 Mar 18, 2026
Kidron Nadav · Director, Officer Grant (A) 167K
Owned 3.4M Trade date Mar 17, 2026 Filed date Mar 18, 2026
Kidron Nadav Director, Officer Grant (A) 167K 3.4M Mar 17, 2026 Mar 18, 2026
Hexter Joshua · Officer Grant (A) 96K
Owned 1.2M Trade date Mar 17, 2026 Filed date Mar 18, 2026
Hexter Joshua Officer Grant (A) 96K 1.2M Mar 17, 2026 Mar 18, 2026
Gabay Avraham · Officer Grant (A) 96K
Owned 745K Trade date Mar 17, 2026 Filed date Mar 18, 2026
Gabay Avraham Officer Grant (A) 96K 745K Mar 17, 2026 Mar 18, 2026
Kidron Nadav · Director, Officer Gift (G) -100K
Owned 3.3M Trade date Mar 12, 2026 Filed date Mar 16, 2026
Kidron Nadav Director, Officer Gift (G) -100K 3.3M Mar 12, 2026 Mar 16, 2026
Hexter Joshua · Officer 2 operations 0
Owned 0 Trade date Jan 22, 2026 Filed date Jan 29, 2026
Hexter Joshua Officer 2 operations 0 0 Jan 22, 2026 Jan 29, 2026
Kidron Miriam · Director, Officer 2 operations 0
Owned 0 Trade date Jan 22, 2026 Filed date Jan 29, 2026
Kidron Miriam Director, Officer 2 operations 0 0 Jan 22, 2026 Jan 29, 2026
Gabay Avraham · Officer 2 operations 0
Owned 0 Trade date Jan 22, 2026 Filed date Jan 29, 2026
Gabay Avraham Officer 2 operations 0 0 Jan 22, 2026 Jan 29, 2026
Kidron Nadav · Director, Officer 2 operations 0
Owned 0 Trade date Jan 22, 2026 Filed date Jan 29, 2026
Kidron Nadav Director, Officer 2 operations 0 0 Jan 22, 2026 Jan 29, 2026
Kidron Miriam · Director Gift (G) -86K
Owned 1.3M Trade date Jan 14, 2026 Filed date Jan 21, 2026
Kidron Miriam Director Gift (G) -86K 1.3M Jan 14, 2026 Jan 21, 2026
15 of 23
15 of 23 Sign in to continue to older insider transactions.

Oramed Pharmaceuticals Inc. (ORMP) activist and large shareholders

Dates
Owner/Filer identity Shares reported % of shares outstanding Filing date
Aquamarine Financial (cayman) Ltd 2.0M
% of shares outstanding 5.1% Filing date May 15, 2026
Aquamarine Financial (cayman) Ltd 2.0M 5.1% May 15, 2026
Kidron Nadav 1.3M
% of shares outstanding 4.1% Filing date Sep 2, 2021
Kidron Nadav 1.3M 4.1% Sep 2, 2021
Bml Investment Partners, L.P. 866K
% of shares outstanding 2.1% Filing date Jun 29, 2026
Bml Investment Partners, L.P. 866K 2.1% Jun 29, 2026
3 of 3

Oramed Pharmaceuticals Inc. (ORMP) ownership FAQ

Who owns ORMP?

59 reporting institutions disclosed ORMP position changes in the Q1 2026 snapshot.

How is institutional activity calculated?

For each manager, WhoBought compares accepted consecutive 13F share counts. Share change is current shares minus prior shares. Estimated dollar change is that signed share change multiplied by the split-adjusted quarter-mean close. The activity table on this page uses Q1 2026.

What are activist and large shareholder filings?

An investor crossing 5% of a share class generally files Schedule 13D for activist intent or Schedule 13G for a passive position. The technical form names appear here rather than in the activity rows.

Where does this data come from?

Ownership and institutional activity come from SEC Form 13F filings. Insider activity comes from SEC Form 4, and large-shareholder activity from SEC Schedules 13D and 13G. FMP supplies price data only. Company logos use the local verified Parqet cache with one shared fallback.

Why are ownership reports delayed?

Form 13F is a quarterly disclosure and is normally filed after the quarter ends. Every ownership and activity value therefore names its represented period; it is not presented as a live position.

How are missing table values shown?

A muted dash marks a missing table value. It means the filing omitted the value, comparable data is unavailable, or no prior position exists for comparison.